{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_000345.4:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Human neuroblastoma SH-SY5Y cells were used for stable overexpression of wild type and mutant a-Syn."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Expression of a-Syn A30P mutant was confirmed by Western blot analysis."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Expression of a-Syn A53T mutant was confirmed by Western blot analysis."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Expression of a-Syn E46K mutant was confirmed by Western blot analysis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected and mock-transfected SH-SY5Y cells served as controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Detection of a 19 kDa band corresponding to a-Syn protein.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Absence of a 19 kDa band corresponding to a-Syn protein.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence Microscopy",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Human neuroblastoma SH-SY5Y cells were used for stable overexpression of wild type and mutant a-Syn."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Bright fluorescence staining confirmed expression of a-Syn A30P mutant."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Bright fluorescence staining confirmed expression of a-Syn A53T mutant."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Bright fluorescence staining confirmed expression of a-Syn E46K mutant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected and mock-transfected SH-SY5Y cells served as controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Bright and evenly distributed fluorescence staining for a-Syn.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Absence or weak fluorescence staining for a-Syn.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "MTT Assay (Acute Toxin Treatment)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Human neuroblastoma SH-SY5Y cells were subjected to acute rotenone and maneb treatment."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P mutant showed significantly lower cell viability following rotenone and maneb treatment compared to untransfected cells."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A53T mutant showed significantly lower cell viability following rotenone and maneb treatment compared to untransfected cells."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "E46K mutant showed significantly lower cell viability following rotenone and maneb treatment compared to untransfected cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Data are expressed as means Â± S.E.M of 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated untransfected cells served as control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis with p < 0.05 considered significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability comparable to or higher than untransfected untreated cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly lower cell viability compared to untransfected untreated cells (p < 0.05).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "MTT Assay (Chronic Toxin Treatment with H2O2 Insult)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Human neuroblastoma SH-SY5Y cells were subjected to chronic rotenone and maneb treatment followed by acute H2O2 insult."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P mutant showed significantly lower cell viability following chronic maneb treatment and H2O2 insult compared to untransfected cells."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A53T mutant showed significantly lower cell viability following chronic maneb treatment and H2O2 insult compared to untransfected cells."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "E46K mutant showed lower cell viability following chronic treatment and H2O2 insult compared to untransfected cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Data are expressed as means Â± S.E.M of 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated untransfected cells served as control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis with p < 0.05 considered significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability comparable to or higher than untransfected untreated cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly lower cell viability compared to untransfected untreated cells (p < 0.05).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Flow Cytometry (ROS Generation and Mitochondrial Membrane Potential)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Human neuroblastoma SH-SY5Y cells were subjected to acute and chronic toxin treatments followed by staining for ROS and mitochondrial membrane potential."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P mutant showed increased ROS levels and greater mitochondrial membrane potential disruption compared to controls."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A53T mutant showed increased ROS levels and greater mitochondrial membrane potential disruption compared to controls."
        },
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "E46K mutant showed increased ROS levels and greater mitochondrial membrane potential disruption compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Data are expressed as means Â± S.E.M of 3 independent experiments."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated untransfected cells served as control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis with p < 0.05 considered significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ROS levels and mitochondrial membrane potential comparable to untransfected untreated cells.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly higher ROS levels or greater mitochondrial membrane potential disruption compared to untransfected untreated cells (p < 0.05).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}